Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia

Condition(s) studied

Investigational drug(s) / intervention(s)

Oral DHA + Topical minoxidil 5%: DHA 20mg tid po plus daily topical minoxidil 5% for 180 days

Topical Minoxidil 5%: Topical minoxidil 5% daily for 180 days

Study summary

The goal of this clinical trial is to learn if dihydroartemisinin (DHA) works to treat Androgenetic Alopecia (AGA) in female adults. The main question it aims to answer is:

• Does DHA increase terminal hair follicles in the vertex area. Researchers will compare oral DHA plus topical minoxidil to topical minoxidil alone in female patients with AGA to see if DHA works to alleviate AGA.

Participants will:

* Receive oral DHA every day plus topical minoxidil or use topical minoxidil alone for 6 months.
* Visit the clinic once every month for checkups and tests.

Eligibility

Primary outcome measure(s)

• Improvement in terminal hair follicles in the vertex area — Baseline and 180-day of treatment
  Terminal hair follicles in the vertex area will be quantified before and at the end of treatment

Trial sites (1)

More Shanghai Zhongshan Hospital trials in China

Other trials for the same condition